US Stocks
/
Protara Therapeutics, Inc. Share Price
Protara Therapeutics, Inc. Share Price

Protara Therapeutics, Inc. Share Price

NASDAQ: TARA | Micro Cap
$3.57
-$0.13 (-3.51%) Last updated on 19 Sep, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Protara Therapeutics, Inc. Stock Performance

Open
$3.66
Prev. Close
$3.70
Circuit Range
N/A
Day Range
$3.45 - $3.72
Year Range
$3.06 - $7.81
Volume
1,37,845
Average Traded
$3.61

Protara Therapeutics, Inc. Share Price Today

As of 19 September 2026, Protara Therapeutics, Inc.'s share price is $3.57. The stock opened at $3.66, compared to its previous close of $3.70. During today's trading session, Protara Therapeutics, Inc.'s share price traded between $3.45 and $3.72, with an average price of $3.58. Over the past 52 weeks, the stock has recorded a high of $7.81 and a low of $3.06. In terms of performance, Protara Therapeutics, Inc.'s share price has declined by 31.35% over the last six months and is down 17.74% on a year-on-year basis.

Protara Therapeutics, Inc. Share Price Chart

$3.45$3.72
L
Show Current Price
H

Protara Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$152.92M
PE Ratio (TTM)
-2.66
Dividend Yield
N/A
EPS (TTM)
$-1.34
Revenue (TTM)
N/A
Return On Equity (TTM)
-29.24%
Profit Margin
N/A
Debt to Equity
0.06
Quarterly Earnings Growth YoY
-18.17%

Protara Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$11.10M-$9.51M-$11.22M-$11.91M-$14.96M-$13.26M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A14.26%-17.93%-6.19%-25.57%11.38%

Protara Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars20212022202320242025
RevenueN/AN/AN/AN/AN/A
Net Profit-$47.25M-$65.95M-$40.42M-$44.60M-$57.44M
Net Profit MarginN/AN/AN/AN/AN/A
Income ChangeN/A-39.58%38.71%-10.33%-28.80%

About Protara Therapeutics, Inc.

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy for patients receiving parenteral nutrition and fluids. The company is headquartered in New York, New York.

Protara Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$3.83
$3.57
-10.64%
Aug 2026
$3.89
$4.00
+1.91%
Jul 2026
$3.88
$3.92
+2.75%
Jun 2026
$4.63
$3.81
-18.13%
May 2026
$5.38
$4.66
-12.57%
Apr 2026
$5.25
$5.33
+2.50%
Mar 2026
$6.28
$5.20
-18.37%
Feb 2026
$7.05
$6.37
-10.16%
Jan 2026
$5.30
$7.09
+33.27%
Dec 2025
$7.25
$5.32
-27.86%
Nov 2025
$5.26
$7.38
+42.37%
Oct 2025
$4.39
$5.18
+19.35%

TARA Share Price FAQs

What is Protara Therapeutics, Inc. share price today?

chevron-up
Protara Therapeutics, Inc. share price today is $3.57 as on September 19, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Protara Therapeutics, Inc. stock?

chevron-up
The 52 week high of Protara Therapeutics, Inc. stock is $7.81, while the 52 week low is $3.06 as of 19 Sep '26.

What is TARA's market capitalisation today?

chevron-up
TARA market capitalisation is $152.92M as of September 19, 2026, at 8:41 am IST.

What is TARA's net income for the last quarter?

chevron-up
TARA's net income for the last quarter is -0.01B USD.

What is the 5 year returns of TARA?

chevron-up
The 5 year returns of TARA is -48.41% as on 19 Sep '26.

What is the high & low stock price of TARA today?

chevron-up
TARA stock price hit a high of $3.72 and low of $3.45 as of 19 Sep '26.

Can I buy TARA shares in India?

chevron-up
Yes. You can buy TARA in India by opening an international trading account.